Teva Buys Japanese Generics Company For $460 Mil.
This article was originally published in PharmAsia News
Executive Summary
Teva Pharmaceutical Industries Ltd. announced May 16 that it is acquiring more than half of Japan's third largest generic drugmaker and extending an offer to purchase the remaining portion of the company